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ABSTRACT 
Atherosclerosis has been established to be an indolent inflammatory disease of the arteries 
which can gives rise to coronary artery disease (CAD), one of the most prevalent causes of 
death in developed and developing countries.  Saffron, one of the world’s most expensive 
spices, is collected from dried stigmas of Crocus sativus L. Saffron exhibits favourable effects 
in the prevention or treatment of a variety of diseases including dyslipidemia, hypertension and 
diabetes mellitus. Our previous in-vitro work showed that Saffron downregulates gene and 
protein expressions of inflammation, endothelial activation and upregulate the gene of 
oxidative stress and inhibit monocyte- endothelial interactions which are the key events in 
pathogenesis of atherosclerosis. Thus, we have translated our research finding into saffron 
formulated drink; Saff-Chol Juice. It can be used as daily healthy drink to combat many 
atherosclerosis complications such as heart attack, stroke and renal failure. It is safe and easy 
to consume. This product may benefit patients with heart problem, hypertension and renal 
failure. It is also useful for smokers who is at risk to develop atherosclerosis.   
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1          INTRODUCTION 
 
Cardiovascular diseases (CVDs) which include coronary heart disease are important 
component in non-communicable diseases (NCDs) which are the world’s biggest killers. An 
estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths 
[1]. In Malaysia, the population-based health survey which is known as the National Health 
and Morbidity Survey (NHMS) in 2015 showed that the prevalence of NCD risk factors 
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continue to rise. It is estimated that 3.5 million adult Malaysians living with diabetes, 6.1 
million with hypertension, 9.6 million with hypercholesterolemia and 3.3 million with obesity 
[2]. The rapid increase in the number of people suffering from NCDs presents one of the biggest 
challenges to the current healthcare system in Malaysia. Therefore, research in recent years has 
sparked great interest among researchers towards prevention and treatment of atherosclerosis 
which is one of the main cause of CVDs. Atherosclerosis has been established to be an indolent 
inflammatory disease of the arteries which can gives rise to coronary artery disease, one of the 
most prevalent causes of death worldwide. Statin, a HMG-coA reductase inhibitor has 
favorable pleiotropic effects on aterosclerosis. Though they have confirmed safety and efficacy 
profile, statins have been reported in epidemiologic and observational studies in which 15% to 
20% of all patients on statin might suffer from different statin-associated adverse effects 
(SAAE) [3].  
 
Saffron, the dried stigmas of Crocus sativus L. have been shown to exhibit favourable effects 
in the prevention and treatment of a variety of diseases such as dyslipidemia, atherosclerosis 
and myocardial ischemia [4]. Our previous in-vitro work showed that Saffron downregulates 
gene and protein expressions of inflammation, endothelial activation and upregulate the gene 
of oxidative stress and inhibit monocyte-endothelial interactions which are the key events in 
pathogenesis of atherosclerosis [5]. Thus, saffron has potential to be promising anti-
atherosclerosis agent. Therefore, we formulated saffron drink; “Saff-Chol Juice” which has 
proven in in vitro study in attenuating atherosclerosis. 
 
2 OBJECTIVE 
 
To translate our research findings into saffron formulated drink, Saff-Chol Juice. 
 
3          SIGNIFICANCE (S) 
 
It is useful for patients with statin intolerance which develop side effects following statin 
administration. It can be used as daily healthy drink to reduce atherosclerosis complications, 
such as heart attack, stroke and renal failure. Therefore, hospital admission, mortality and 
morbidity rate, and financial burden of healthcare could also be reduced.      
 
4 METHODOLOGY/TECHNIQUE 
 
Saffron stigmas were tested for their effect on atherosclerosis by using human coronary artery 
endothelial cell (HCAEC). The significant amount to cause the atherosclerotic changes were 
determined. Crude saffron was later formulated as a juice in 250 ml amount which contain 
significant amount of saffron that has been proven in vitro study to cause significant effect in 
reducing atherosclerosis. Market survey on saffron juice prototype was done to 200 random 
people through online survey to get respondent feedback on the interest to buy the product.  
 
 
5 RESULT 
 
Saffron downregulates gene and protein expressions of inflammation, endothelial activation 
and upregulate the gene of oxidative stress and inhibit monocyte- endothelial interaction which 
are the key events in pathogenesis of atherosclerosis (Table 1). 250 ml Saff-Chol Juice 
prototype is produced with completed packaging bottle (see Fig 1). Market survey showed 89.0 
% of respondents would be interested to buy the product (see Fig 2).   
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Table 1. Effect of Saffron on various atherosclerosis markers. 
Atherosclerosis Marker Minimum Saffron concentration (ug/mL) that cause significant 
changes of atherosclerosis marker 
p-value 
eNOS  25 < 0.05 
DCFHDA 31.3 < 0.01 
IL-6 protein expression 3.1 <0.05 
IL-8 protein expression 25 <0.05 
IL-6 gene expression 25 < 0.01 
IL-8 gene expression - - 
NF-κB p50 protein expression 25 <0.01 
NF-κB p65 protein expression 25 <0.05 
NF-κB p50 gene expression 12.5 <0.05 
NF-κB p65 gene expression 25 <0.05 
sICAM-1 protein expression 3.13 <0.01 
sVCAM-1 protein expression 3.13 <0.05 
E-selectin protein expression 12.5 <0.01 
sICAM-1 gene expression 12.5 <0.05 
sVCAM-1 gene expression 3.13 <0.05 
E-selectin gene expression 6.25 <0.05 
 
eNOs: endothelial nitric oxide synthase; DCFHDA: 2′,7′-Dichlorofluorescin diacetate, IL: 
interleukin; NF-κB: nuclear factor-kappa beta, sICAM-1: soluble intercellular adhesion 
molecule-1, sVCAM-1: soluble vascular cell adhesion molecule-1.  
 
                                            
 
Fig. 1 Poster of Saff-Chol Juice 
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Fig. 2 Market survey showing the percentage and total number of respondents that interested to buy Saff-Chol Juice. 
 
 
6 CONCLUSION 
 
Saff-Chol juice could be used as natural supplement to reduce atherosclerosis. Further testing 
of Saffron on animal study and randomised control trial would be beneficial to improve the 
formulation of Saff-Chol juice.  
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